Institut Bergonie

Bordeaux, Aquitaine 33076

1 studies enrolling now · 3 studies all time

What they study most

Cancer Harboring BRAF Alterations, Epithelial Ovarian Cancer, Fallopian Tube Cancer, HGG, LGG, Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma, Ovarian Cancer, Peritoneal Cancer, Solid Tumors

Studies at this site

• A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations — Recruiting now
• Phase 3 Study to Treat Patients With Soft Tissue Sarcomas — Completed
• A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) — Completed